CytomX Therapeutics (CTMX) Short Interest Ratio & Short Volume $0.87 -0.02 (-2.25%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CytomX Therapeutics Short Interest DataCytomX Therapeutics (CTMX) has a short interest of 5.67 million shares. This marks a -6.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.4, indicating that it would take 7.4 days of the average trading volume of 2.51 million shares to cover all short positions.Current Short Interest5,670,000 sharesPrevious Short Interest6,070,000 sharesChange Vs. Previous Month-6.59%Dollar Volume Sold Short$5.65 millionShort Interest Ratio7.4 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares78,260,000 sharesPercentage of Shares Shorted7.25%Today's Trading Volume428,324 sharesAverage Trading Volume2,511,455 sharesToday's Volume Vs. Average17% Short Selling CytomX Therapeutics? Sign up to receive the latest short interest report for CytomX Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCTMX Short Interest Over TimeCTMX Days to Cover Over TimeCTMX Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide CytomX Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20245,670,000 shares $5.65 million -6.6%N/A7.4 $1.00 10/15/20246,070,000 shares $6.80 million -2.9%N/A9.4 $1.12 9/30/20246,250,000 shares $7.38 million -10.5%N/A9.1 $1.18 9/15/20246,980,000 shares $8.59 million -2.4%N/A8.2 $1.23 8/31/20247,150,000 shares $8.44 million -9.2%N/A6.5 $1.18 8/15/20247,870,000 shares $9.37 million +1.7%N/A6 $1.19 Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20247,740,000 shares $10.68 million No ChangeN/A2.5 $1.38 7/15/20247,740,000 shares $10.91 million -3.9%N/A1.2 $1.41 6/30/20248,050,000 shares $9.82 million +3.7%N/A1.2 $1.22 6/15/20247,760,000 shares $10.71 million -1.8%N/A1.2 $1.38 5/31/20247,900,000 shares $13.43 million -9.7%N/A1.2 $1.70 5/15/20248,750,000 shares $17.15 million +143.1%N/A1.4 $1.96 4/30/20243,600,000 shares $5.87 million +0.3%N/A0.6 $1.63 4/15/20243,590,000 shares $7.07 million +8.1%N/A4 $1.97 3/31/20243,320,000 shares $7.24 million -6.0%N/A3.8 $2.18 3/15/20243,530,000 shares $7.31 million +115.2%N/A4.1 $2.07 2/29/20241,640,000 shares $4.02 million +26.2%N/A2.2 $2.45 2/15/20241,300,000 shares $1.95 million +4.0%N/A2.8 $1.50 1/31/20241,250,000 shares $1.91 million -5.3%N/A4.2 $1.53 1/15/20241,320,000 shares $2.28 million -0.8%N/A4.4 $1.73 12/31/20231,330,000 shares $2.06 million +35.5%N/A4.9 $1.55 12/15/2023981,600 shares $1.38 million -26.8%N/A5 $1.41 11/30/20231,340,000 shares $1.86 million +0.8%N/A7.5 $1.39 11/15/20231,330,000 shares $1.72 million +5.6%N/A8 $1.29 10/31/20231,260,000 shares $1.39 million -18.2%N/A7 $1.10 10/15/20231,540,000 shares $1.93 million -9.9%N/A8.5 $1.25 9/30/20231,710,000 shares $2.21 million -23.0%N/A9.5 $1.29 9/15/20232,220,000 shares $3.06 million +2.3%N/A8.2 $1.38 8/31/20232,170,000 shares $3.26 million +5.9%N/A7.5 $1.50 8/15/20232,050,000 shares $3.26 million -21.5%N/A6.5 $1.59 7/31/20232,610,000 shares $4.54 million -3.0%4.0%7 $1.74 7/15/20232,690,000 shares $4.90 million +13.0%4.1%6.8 $1.82 6/30/20232,380,000 shares $4.09 million No Change3.7%5.3 $1.72 6/15/20232,380,000 shares $3.71 million +4.4%3.7%4.5 $1.56 5/31/20232,280,000 shares $3.90 million +7.0%3.5%3.4 $1.71 5/15/20232,130,000 shares $3.88 million -13.4%3.3%2.8 $1.82 4/30/20232,460,000 shares $4.01 million +9.3%3.8%2.8 $1.63 4/15/20232,250,000 shares $3.74 million +40.6%3.5%2 $1.66 3/31/20231,600,000 shares $2.42 million -14.9%2.5%1 $1.51 3/15/20231,880,000 shares $3.82 million +48.0%2.9%0.8 $2.03This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 2/28/20231,270,000 shares $2.73 million -8.0%2.0%0.5 $2.15 2/15/20231,380,000 shares $3.20 million -13.8%2.1%0.5 $2.32 1/31/20231,600,000 shares $4.32 million -43.3%2.5%0.5 $2.70 1/15/20232,820,000 shares $8.07 million +433.7%4.3%1 $2.86 12/30/2022528,400 shares $845,440.00 -64.1%0.8%0.2 $1.60 12/15/20221,470,000 shares $2.34 million -26.1%2.3%1.1 $1.59 11/30/20221,990,000 shares $3.46 million +103.7%3.1%1.6 $1.74 11/15/2022977,100 shares $1.16 million -2.0%1.5%0.8 $1.19 10/31/2022997,400 shares $1.31 million -6.8%1.6%2 $1.31 10/15/20221,070,000 shares $1.52 million -10.8%1.7%1.6 $1.42 9/30/20221,200,000 shares $1.74 million +2.6%1.9%1.3 $1.45 9/15/20221,170,000 shares $1.94 million +30.9%1.9%0.7 $1.66 8/31/2022894,100 shares $1.34 million -14.0%1.4%0.5 $1.50 8/15/20221,040,000 shares $1.80 million -21.2%1.7%0.6 $1.73 7/31/20221,320,000 shares $1.89 million +1.5%2.1%0.7 $1.43 7/15/20221,300,000 shares $1.95 million +10.2%2.1%0.7 $1.50 6/30/20221,180,000 shares $2.16 million -67.7%1.9%0.7 $1.83 6/15/20223,650,000 shares $6.28 million -4.5%5.9%3.2 $1.72 5/31/20223,820,000 shares $6.15 million -5.5%6.1%3.5 $1.61 5/15/20224,040,000 shares $7.11 million +6.3%6.5%3.8 $1.76 4/30/20223,800,000 shares $6.50 million +37.7%6.2%3.9 $1.71 4/15/20222,760,000 shares $6.38 million -29.6%4.5%3.2 $2.31 3/31/20223,920,000 shares $10.47 million +2.6%6.4%4.4 $2.67 3/15/20223,820,000 shares $11.38 million No Change6.3%3.2 $2.98 2/28/20223,820,000 shares $14.63 million -2.1%6.3%3.4 $3.83 2/15/20223,900,000 shares $15.91 million +11.4%6.4%3.2 $4.08 1/31/20223,500,000 shares $16.10 million -5.4%5.6%2.7 $4.60 1/15/20223,700,000 shares $14.62 million +19.4%5.9%2.9 $3.95 12/31/20213,100,000 shares $13.42 million -22.3%5.0%2.6 $4.33 12/15/20213,990,000 shares $26.65 million +9.0%6.4%3.6 $6.68 11/30/20213,660,000 shares $24.19 million -21.8%5.9%5.3 $6.61 11/15/20214,680,000 shares $33.98 million -3.3%7.5%7.6 $7.26 10/29/20214,840,000 shares $28.70 million +7.6%7.7%8.1 $5.93 10/15/20214,500,000 shares $23.13 million -7.4%7.2%8.1 $5.14 9/30/20214,860,000 shares $24.74 million -7.3%7.7%8.1 $5.09 9/15/20215,240,000 shares $26.04 million -11.2%8.3%7.6 $4.97 8/31/20215,900,000 shares $30.21 million -11.7%9.4%8.6 $5.12 8/13/20216,680,000 shares $32.40 million -4.4%10.6%9.2 $4.85 7/30/20216,990,000 shares $37.82 million +5.1%10.9%9.3 $5.41 7/15/20216,650,000 shares $39.10 million +0.2%10.4%7.5 $5.88 6/30/20216,640,000 shares $42.03 million -0.6%10.4%7 $6.33 6/15/20216,680,000 shares $47.29 million +0.6%10.5%7.2 $7.08 5/28/20216,640,000 shares $47.54 million -1.3%10.4%6.8 $7.16 5/14/20216,730,000 shares $55.39 million +1.1%N/A6.8 $8.23 4/30/20216,660,000 shares $63.20 million +7.6%N/A6.6 $9.49 4/15/20216,190,000 shares $44.69 million -3.4%N/A6.2 $7.22 3/31/20216,410,000 shares $47.43 million +63.5%N/A6.2 $7.40 3/15/20213,920,000 shares $33.32 million +17.7%N/A3.9 $8.50 2/26/20213,330,000 shares $26.17 million No ChangeN/A3.7 $7.86 2/12/20213,330,000 shares $27.44 million -8.5%N/A3.9 $8.24This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 1/29/20213,640,000 shares $25.52 million +20.9%N/A4.6 $7.01 1/15/20213,010,000 shares $23.63 million +3.8%N/A4.4 $7.85 12/31/20202,900,000 shares $19.78 million -3.3%6.5%6.2 $6.82 12/15/20203,000,000 shares $23.70 million -8.8%6.7%6.8 $7.90 11/30/20203,290,000 shares $24.41 million -10.1%7.4%7.9 $7.42 11/15/20203,660,000 shares $27.08 million -7.3%8.2%9 $7.40 10/30/20203,950,000 shares $26.74 million +16.2%8.8%9.7 $6.77 10/15/20203,400,000 shares $23.02 million +10.8%7.6%8 $6.77 9/30/20203,070,000 shares $20.42 million -7.0%6.8%7.2 $6.65 9/15/20203,300,000 shares $23.83 million -6.0%7.4%7.3 $7.22 8/31/20203,510,000 shares $25.62 million +5.7%7.8%7.3 $7.30 8/14/20203,320,000 shares $22.78 million +3.1%7.4%6.1 $6.86 7/31/20203,220,000 shares $22.57 million +20.6%7.2%5.1 $7.01 7/15/20202,670,000 shares $22.83 million -15.8%6.0%4 $8.55 6/30/20203,170,000 shares $26.41 million +88.7%7.2%4.7 $8.33 6/15/20201,680,000 shares $13.37 million +40.0%3.8%2.4 $7.96 5/29/20201,200,000 shares $10.63 million +1.7%2.7%1.8 $8.86 5/15/20201,180,000 shares $10.63 million +10.3%2.7%1.8 $9.01 4/30/20201,070,000 shares $11.04 million -14.4%2.4%2 $10.32 4/15/20201,250,000 shares $10.96 million +44.6%2.8%2.6 $8.77 3/31/2020864,300 shares $8.04 million -39.3%2.0%1.9 $9.30 3/13/20201,423,800 shares $12.20 million +11.2%3.2%3.1 $8.57 2/28/20201,280,000 shares $6.31 million +10.3%2.9%3 $4.93 2/14/20201,160,000 shares $7.49 million -11.5%2.6%2.7 $6.46 1/31/20201,310,000 shares $9.51 million -14.9%3.0%3 $7.26 1/15/20201,540,000 shares $11.18 million -1.3%3.5%3.5 $7.26 12/31/20191,560,000 shares $11.70 million -32.8%3.5%3.2 $7.50 CTMX Short Interest - Frequently Asked Questions What is CytomX Therapeutics' current short interest? Short interest is the volume of CytomX Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 5,670,000 shares of CTMX short. Learn More on CytomX Therapeutics' current short interest. What is a good short interest ratio for CytomX Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTMX shares currently have a short interest ratio of 7.0. Learn More on CytomX Therapeutics's short interest ratio. Is CytomX Therapeutics' short interest increasing or decreasing? CytomX Therapeutics saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 5,670,000 shares, a decrease of 6.6% from the previous total of 6,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CytomX Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CytomX Therapeutics: DURECT Co. (3.35%), MEI Pharma, Inc. (1.23%), Eton Pharmaceuticals, Inc. (0.78%), UroGen Pharma Ltd. (28.14%), Atea Pharmaceuticals, Inc. (3.50%), Atai Life Sciences (8.06%), Poseida Therapeutics, Inc. (4.50%), Fate Therapeutics, Inc. (13.96%), Atyr PHARMA INC (2.03%), Benitec Biopharma Inc. (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short CytomX Therapeutics stock? Short selling CTMX is an investing strategy that aims to generate trading profit from CytomX Therapeutics as its price is falling. CTMX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytomX Therapeutics? A short squeeze for CytomX Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CTMX, which in turn drives the price of the stock up even further. How often is CytomX Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTMX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies DRRX Short Interest MEIP Short Interest PSTX Short Interest ETON Short Interest AVIR Short Interest ATAI Short Interest URGN Short Interest LFCR Short Interest ATYR Short Interest FATE Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTMX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTMX Stock Alerts